What Is Quality by Design and Why Do Pharma Teams Need It?UntitledBuilding Quality in, Not Testing It In
Quality by Design (QbD) is a systematic, science-based approach to pharmaceutical and biopharmaceutical development that builds quality into a product from the design stage rather than testing it in at the end. This Quality by Design Training in Spain shows pharmaceutical professionals how to apply that approach in practice, using the ICH Q8(R2), Q9, Q10 and Q11 guidelines that regulators such as the EMA and FDA now expect behind every development and manufacturing submission. The programme is built around the tools that make QbD work on the job: the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment, Design of Experiments (DoE), the design space and the control strategy. You learn to link material attributes and process parameters to product quality, so you can predict and control quality instead of inspecting for it after the fact. It suits formulation, analytical and process development scientists, QA professionals and CMC regulatory specialists across Spain's pharma clusters in Catalonia, Madrid and Valencia. Delivered in live virtual, classroom and corporate formats, the training turns ICH theory into skills you can apply to real product development from day one.










